NKE should do fine into the foreseeable future.
It has a somewhat predictable seasonable price history taking it up from midyear to January in cycles.
And the above 3917% does not include all those dividend payments and call premiums over those 19 years!
In the egg business long term holders get paid.
3917% rise since CALM went public 19 years ago.
Cash is: $21,322,000,000
Should be enough to carry them through.
Pipeline registry on FDA clinicaltrials dot gov is excellent also.